Sally-Ann Cryan

Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Increased intracellular targeting to airway cells using octaarginine-coated liposomes: in vitro assessment of their suitability for inhalation.

The development of a tissue-engineered tracheobronchial epithelial model using a bilayered collagen-hyaluronate scaffold.

Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery.

Biopolymer-Based Nanoparticles for Cystic Fibrosis Lung Gene Therapy Studies.

Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.

Knockdown of Gene Expression in Macrophages by microRNA Mimic-Containing Poly (Lactic--glycolic Acid) Microparticles.

Transfection of autologous host cells in vivo using gene activated collagen scaffolds incorporating star-polypeptides.

Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.

Corrigendum to "Transfection of autologous host cells in vivo using gene activated collagen scaffolds incorporating star-polypeptides" [J. Control. Release 304(2019) 191-203].